HPR180 Eligibility of Orphan Drugs for Preferential Reimbursement in Egypt
Autor: | Fasseeh, AN, Elezbawy, B, Korra, N, Roushdy, M, Seyam, A, Hayek, N, Abdel Rahman, N, Abdelhamid, S, Fasseeh, N, Saad, AS, Elagamy, A, Mahmoud, A, Sedrak, AS, Elshazly, K, Eldebeiky, M, Talaat, M, Maher, N, Abdelaziz, R, Refaat, R, Akeel, S, Adel, R, Khalil, S, Abaza, S, Kalo, Z |
---|---|
Zdroj: | In Value in Health December 2022 25(12) Supplement:S265-S265 |
Databáze: | ScienceDirect |
Externí odkaz: |